- Home
- MMD vs VTAK Comparison
MMD vs VTAK Comparison
Compare MMD & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMD
- VTAK
- Stock Information
- Founded
- MMD 2012
- VTAK 2002
- Country
- MMD United States
- VTAK United States
- Employees
- MMD N/A
- VTAK N/A
- Industry
- MMD Investment Managers
- VTAK Medical/Dental Instruments
- Sector
- MMD Finance
- VTAK Health Care
- Exchange
- MMD Nasdaq
- VTAK Nasdaq
- Market Cap
- MMD N/A
- VTAK 2.7M
- IPO Year
- MMD N/A
- VTAK 2018
- Fundamental
- Price
- MMD $14.81
- VTAK $0.32
- Analyst Decision
- MMD
- VTAK
- Analyst Count
- MMD 0
- VTAK 0
- Target Price
- MMD N/A
- VTAK N/A
- AVG Volume (30 Days)
- MMD 74.7K
- VTAK 119.1K
- Earning Date
- MMD 01-01-0001
- VTAK 05-05-2025
- Dividend Yield
- MMD 4.88%
- VTAK N/A
- EPS Growth
- MMD N/A
- VTAK N/A
- EPS
- MMD N/A
- VTAK N/A
- Revenue
- MMD N/A
- VTAK $420,000.00
- Revenue This Year
- MMD N/A
- VTAK $38.46
- Revenue Next Year
- MMD N/A
- VTAK $533.33
- P/E Ratio
- MMD N/A
- VTAK N/A
- Revenue Growth
- MMD N/A
- VTAK 27.07
- 52 Week Low
- MMD $14.30
- VTAK $0.30
- 52 Week High
- MMD $17.67
- VTAK $8.40
- Technical
- Relative Strength Index (RSI)
- MMD 34.06
- VTAK 40.48
- Support Level
- MMD $14.95
- VTAK $0.36
- Resistance Level
- MMD $15.29
- VTAK $0.37
- Average True Range (ATR)
- MMD 0.25
- VTAK 0.03
- MACD
- MMD -0.02
- VTAK -0.01
- Stochastic Oscillator
- MMD 6.58
- VTAK 0.00
Stock Price Comparison Chart: MMD vs VTAK
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.